AF
Avanza Fonder Portfolio holdings
AUM
$3.38B
This Quarter Return
+14.45%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.38B
AUM Growth
+$328M
(+11%)
Cap. Flow
+$50M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
44.57%
Holding
492
New
32
Increased
115
Reduced
114
Closed
59
Top Buys
| 1 |
Microsoft
MSFT
|
+$18.4M |
| 2 |
Tesla
TSLA
|
+$17.1M |
| 3 |
Amazon
AMZN
|
+$16.6M |
| 4 |
Intuit
INTU
|
+$14.9M |
| 5 |
GE Vernova
GEV
|
+$13.7M |
Top Sells
| 1 |
McDonald's
MCD
|
+$14.4M |
| 2 |
Intel
INTC
|
+$11.4M |
| 3 |
Toronto Dominion Bank
TD
|
+$9.83M |
| 4 |
NVIDIA
NVDA
|
+$8.89M |
| 5 |
American Tower
AMT
|
+$6.77M |
Sector Composition
| 1 | Technology | 37.73% |
| 2 | Consumer Discretionary | 14.58% |
| 3 | Financials | 12.02% |
| 4 | Communication Services | 10.72% |
| 5 | Healthcare | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
NewAmsterdam Pharma
NAMS
$2.83B
| $136K | ﹤0.01% |
7,505
+1,300
| +21% | +$23.5K |
|
402
Revolution Medicines
RVMD
$7.68B
| $136K | ﹤0.01% |
3,688
+811
| +28% | +$29.8K |
|
403
Krystal Biotech
KRYS
$4.2B
| $129K | ﹤0.01% |
941
-319
| -25% | -$43.9K |
|
404
Weave Communications
WEAV
$608M
| $125K | ﹤0.01% |
14,971
+1,819
| +14% | +$15.1K |
|
|
AUTL
405
Autolus Therapeutics
AUTL
$381M
| $122K | ﹤0.01% |
53,522
+32,246
| +152% | +$73.5K |
|
406
Bioceres Crop Solutions
BIOX
$161M
| $117K | ﹤0.01% |
26,164
+10,099
| +63% | +$45.1K |
|
407
Alarm.com
ALRM
$2.84B
| $112K | ﹤0.01% |
1,975
| – | – |
|
408
Lennar Class B
LEN.B
$35.4B
| $105K | ﹤0.01% |
994
| – | – |
|
409
Cavco Industries
CVCO
$4.32B
| $104K | ﹤0.01% |
239
-141
| -37% | -$61.3K |
|
|
MREO
410
Mereo BioPharma
MREO
$285M
| $104K | ﹤0.01% |
38,235
+10,114
| +36% | +$27.4K |
|
411
Montrose Environmental
MEG
$1.03B
| $103K | ﹤0.01% |
4,700
| – | – |
|
412
Health Catalyst
HCAT
$238M
| $98.2K | ﹤0.01% |
26,050
| – | – |
|
413
Summit Therapeutics
SMMT
$14.4B
| $95.5K | ﹤0.01% |
4,487
-1,048
| -19% | -$22.3K |
|
414
Energy Recovery
ERII
$776M
| $93K | ﹤0.01% |
7,274
| – | – |
|
415
Harmony Biosciences
HRMY
$2.06B
| $92.4K | ﹤0.01% |
2,924
| – | – |
|
416
CryoPort
CYRX
$503M
| $81.2K | ﹤0.01% |
10,882
+2,601
| +31% | +$19.4K |
|
417
Bright Horizons
BFAM
$6.62B
| $80.6K | ﹤0.01% |
652
| – | – |
|
418
Arcellx
ACLX
$3.94B
| $80.3K | ﹤0.01% |
1,219
-424
| -26% | -$27.9K |
|
419
Kadant
KAI
$3.84B
| $80K | ﹤0.01% |
252
-44
| -15% | -$14K |
|
420
Cummins
CMI
$54.8B
| $78.6K | ﹤0.01% |
240
| – | – |
|
421
Neogen
NEOG
$1.23B
| $78.6K | ﹤0.01% |
16,435
+2,499
| +18% | +$11.9K |
|
422
Janux Therapeutics
JANX
$1.49B
| $68.4K | ﹤0.01% |
2,960
-89
| -3% | -$2.06K |
|
|
BCAX
423
Bicara Therapeutics Inc. Common Stock
BCAX
$671M
| $61K | ﹤0.01% |
6,567
-86
| -1% | -$799 |
|
424
Core & Main
CNM
$12.6B
| $60.3K | ﹤0.01% |
999
| – | – |
|
425
Disc Medicine
IRON
$2.15B
| $57.4K | ﹤0.01% |
+1,083
| New | +$57.4K |
|